
overview focuses on various factors that affect the scalability of parenteral, it covers different factor right from environmental factors to pakaging and also covered some shipment and handling challenges after scale up as well, we had tried to give formulators an overview that will help them to understand the scale up challenge they must consider at the time of developing the strategy to develop parenteral formulation with the intent to raise the ratio of drug discovered and comercialized, as we see out many of drug molecule discovered very little have been scaled up, the article also gives solution to many of the problems encountered although it is in general term and may vary with different molecule. Formulators can get an overview of challenges they might face during scale up so they can handle during development stage that lead to ease in scelability
Lyophilization, homogenization, sterility, stability, primary packaging, Microfluidics
Lyophilization, homogenization, sterility, stability, primary packaging, Microfluidics
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
